These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 74675)

  • 21. The effects of putative 5-hydroxytryptamine antagonists on the behaviour produced by administration of tranylcypromine and L-tryptophan or tranylcypromine and L-DOPA to rats.
    Deakin JF; Green AR
    Br J Pharmacol; 1978 Oct; 64(2):201-9. PubMed ID: 708990
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antidepressant action of electroconvulsive therapy.
    Essman WB
    Lancet; 1978 Apr; 1(8070):935. PubMed ID: 76868
    [No Abstract]   [Full Text] [Related]  

  • 23. Growth and behavioral changes in developing rats treated intracisternally with 6-hydroxydopamine: evidence for involvement of brain dopamine.
    Smith RD; Cooper BR; Breese GR
    J Pharmacol Exp Ther; 1973 Jun; 185(3):609-19. PubMed ID: 4145870
    [No Abstract]   [Full Text] [Related]  

  • 24. Time studies on the effects of tranylcypromine plus tryptophan on formation of tryptamine and 5-hydroxytryptamine in rat brain.
    Hay JL; McKim HR; Baker GB; Dewhurst WG
    Proc West Pharmacol Soc; 1982; 25():133-5. PubMed ID: 7122487
    [No Abstract]   [Full Text] [Related]  

  • 25. Some observations on the behavioural and biochemical effects of L-tryptophan plus a monoamine oxidase inhibitor in immature rats [proceedings].
    Atterwill CK; Costain DW; Green AR
    Br J Pharmacol; 1979 May; 66(1):118P-119P. PubMed ID: 454914
    [No Abstract]   [Full Text] [Related]  

  • 26. Studies on possible mechanisms of action of electroconvulsive therapy; effects of repeated electrically induced seizures on rat brain receptors for monoamines and other neurotransmitters.
    Deakin JF; Owen F; Cross AJ; Dashwood MJ
    Psychopharmacology (Berl); 1981; 73(4):345-9. PubMed ID: 6265964
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Study of a mechanism responsible for potential antidepressant activity of EMD 386088, a 5-HT6 partial agonist in rats.
    Jastrzębska-Więsek M; Siwek A; Partyka A; Antkiewicz-Michaluk L; Michaluk J; Romańska I; Kołaczkowski M; Wesołowska A
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Aug; 389(8):839-49. PubMed ID: 27106213
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The aggressive monoamines.
    Eichelman BS; Thoa NB
    Biol Psychiatry; 1973 Apr; 6(2):143-64. PubMed ID: 4736194
    [No Abstract]   [Full Text] [Related]  

  • 29. Role of tryptamine in the behavioural changes caused by a monoamine oxidase inhibitor and L-tryptophan [proceedings].
    Curzon G; Marsden CA
    Br J Pharmacol; 1977 Jun; 60(2):307P-308P. PubMed ID: 880472
    [No Abstract]   [Full Text] [Related]  

  • 30. Relationship of dopamine neural systems to the behavioral alterations produced by 6-hydroxydopamine administration into brain.
    Cooper BR; Breese GR
    Adv Biochem Psychopharmacol; 1974; 12(0):353-68. PubMed ID: 4609223
    [No Abstract]   [Full Text] [Related]  

  • 31. Increased fixed-ratio performance and differential d- and l-amphetamine action following norepinephrine depletion by intraventricular 6-hydroxydopamine.
    Peterson DW; Sparber SB
    J Pharmacol Exp Ther; 1974 Dec; 191(3):349-57. PubMed ID: 4427285
    [No Abstract]   [Full Text] [Related]  

  • 32. The influence of bufotenin on the feeding behavior and cerebral serotonin content in rats.
    Uluitu M; Lazăr M; Catrinescu G
    Physiologie; 1976; 13(2):145-53. PubMed ID: 821071
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effects of Ca2+ antagonists and hydralazine on central 5-hydroxytryptamine biochemistry and function in rats and mice.
    Green AR; DeSouza RJ; Davies EM; Cross AJ
    Br J Pharmacol; 1990 Jan; 99(1):41-6. PubMed ID: 1691944
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Studies on maxindol as an amine uptake inhibitor.
    Fuller RW; Snoddy HD; Wong DT; Bymaster FP
    Commun Psychopharmacol; 1978; 2(3):223-30. PubMed ID: 699537
    [No Abstract]   [Full Text] [Related]  

  • 35. The role of brain 5-hydroxytryptamine in the hyperactivity produced in rats by lithium and monoamine oxidase inhibition.
    Grahame-Smith DG; Green AR
    Br J Pharmacol; 1974 Sep; 52(1):19-26. PubMed ID: 4281339
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacological studies on serotonin-mediated behaviour.
    Green AR
    J Physiol (Paris); 1981; 77(2-3):437-47. PubMed ID: 6457143
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of monoamine oxidase inhibition by clorgyline, deprenil or tranylcypromine on 5-hydroxytryptamine concentrations in rat brain and hyperactivity following subsequent tryptophan administration.
    Green AR; Youdim MB
    Br J Pharmacol; 1975 Nov; 55(3):415-22. PubMed ID: 1203627
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Iron deficiency and neurotransmitter synthesis and function.
    Youdim MB; Green AR
    Proc Nutr Soc; 1978 Sep; 37(2):173-9. PubMed ID: 30090
    [No Abstract]   [Full Text] [Related]  

  • 39. Role of tryptaminergic mechanisms in the elements of the behavioural syndrome evoked by tryptophan and a monoamine oxidase inhibitor [proceedings].
    Crow TJ; Deakin JF
    Br J Pharmacol; 1977 Mar; 59(3):461P. PubMed ID: 843707
    [No Abstract]   [Full Text] [Related]  

  • 40. A study of the central effects of 5,6-dihydroxytryptamine.
    Longo VG; Scotti de Carolis A; Liuzzi A; Massotti M
    Adv Biochem Psychopharmacol; 1974; 10():109-20. PubMed ID: 4546514
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.